Takara Bio USA announces Carol Lou's retirement and appoints Andrew Farmer as President and CEO

A leadership transition after 20 years of service, carrying forward Takara Bio USA's commitment to research innovation.

Date

June 8, 2026

Location

San Jose, California

Read time

3 min read

A broader path to discovery

Takara Bio USA today announced the retirement of Carol Lou and the appointment of Andrew Farmer, PhD, as President and Chief Executive Officer. The transition maintains continuity across research and development, manufacturing and commercial operations.

The expanded portfolio supports deeper biological insight from multiomics experiments while remaining designed for seamless integration. Researchers can add a new dimension to existing studies without purchasing a separate specialized instrument or abandoning the platforms already used in their laboratories.

“

The next chapter builds on two decades of investment in the tools researchers rely on every day.

Technology unlocks new possibilities

Single-cell spatial omics is redefining how scientists study tissue biology by enabling high-resolution maps of gene and protein expression. A straightforward workflow transforms standard single-cell data into spatial insight, and expanded bioinformatics software with dedicated field-application support helps researchers optimize downstream analysis with open-source tools.

Investing in what comes next

Takara Bio USA continues to expand its R&D teams and consolidate manufacturing at its facilities. The investment increases capacity to scale production, respond to global demand, and accelerate development of complementary platforms.